| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $74,625,510 ) (Continued on the next page) |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U24DK085532 | Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating Center | 001 | 14 | NIH | 8/25/2022 | $28,738 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U24DK085532 | Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating Center | 002 | 14 | NIH | 9/8/2022 | $89,267 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U01CA232216 | Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer | 000 | 4 | NIH | 8/11/2022 | $612,300 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | P20CA242619 | 1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership | 000 | 4 | NIH | 8/29/2022 | $211,607 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 001 | 3 | NIH | 5/12/2022 | $34,598 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 000 | 3 | NIH | 3/25/2022 | $389,186 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA238429 | Exploring the preclinical relevance of therapeutic radiolabeled daratumumab (anti-CD38) in combination with anti-CS1 CAR T cells as a novel combinatorial treatment for multiple myeloma | 000 | 4 | NIH | 7/15/2022 | $394,548 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL145170 | Long non-coding RNA-mediated chromatin remodeling in angiogenesis | 000 | 4 | NIH | 7/6/2022 | $499,426 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA240392 | The role of O-GlcNAcylation in DNA damage repair and cancer therapy | 000 | 4 | NIH | 6/21/2022 | $387,823 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA233664 | DNA repair gene mutations and prostate cancer | 001 | 3 | NIH | 4/29/2022 | $55,820 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA233664 | DNA repair gene mutations and prostate cancer | 000 | 3 | NIH | 11/18/2021 | $627,975 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01GM133850 | Regulation of N6-methyladenosine (m6A) deposition by arginine methylation | 000 | 4 | NIH | 4/6/2022 | $332,640 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01GM133850 | Regulation of N6-methyladenosine (m6A) deposition by arginine methylation | 001 | 4 | NIH | 7/27/2022 | $36,960 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK124116 | The function and underlying mechanism of TET1 in myelodysplastic syndromes | 001 | 3 | NIH | 3/30/2022 | $55,486 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK124116 | The function and underlying mechanism of TET1 in myelodysplastic syndromes | 000 | 3 | NIH | 1/11/2022 | $499,368 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA240111 | Interdisciplinary Communication Training in Oncology | 000 | 3 | NIH | 2/3/2022 | $308,044 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA247368 | Fatty acids and their receptors-mediated tumor metastasis and progression | 001 | 3 | NIH | 5/24/2022 | $32,208 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA247368 | Fatty acids and their receptors-mediated tumor metastasis and progression | 000 | 3 | NIH | 1/11/2022 | $362,340 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA225843 | RECQ5-dependent SUMO2 conjugation of PCNA in the resolution of transcription-replication conflicts | 001 | 4 | NIH | 5/13/2022 | $31,659 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA225843 | RECQ5-dependent SUMO2 conjugation of PCNA in the resolution of transcription-replication conflicts | 000 | 4 | NIH | 1/31/2022 | $356,164 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U24DK104162 | Human Islet Research Enhancement Center for the Human Islet Research Network | 001 | 9 | NIH | 8/2/2022 | $1,499,999 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U24DK104162 | Human Islet Research Enhancement Center for the Human Islet Research Network | 002 | 9 | NIH | 9/8/2022 | $1,000,000 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U24DK104162 | Human Islet Research Enhancement Center for the Human Islet Research Network | 002 | 9 | NIH | 9/8/2022 | -$1,000,000 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R35HG010721 | Scalable tools to effectively translate genomic discoveries into the clinic | 001 | 4 | NIH | 7/1/2022 | $524,898 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AG063854 | Defining the Role of Adipogenesis in Age-Associated Adiposity | 000 | 3 | NIH | 5/18/2022 | $360,800 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA227230 | (PQ11) Immune modulatory effects of white button mushroom in prostate cancer - A translational research | 000 | 4 | NIH | 8/23/2022 | $655,944 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA236626 | Role of BAZ2A in MLL-r leukemia and therapeutic response | 001 | 4 | NIH | 6/17/2022 | $39,574 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA236626 | Role of BAZ2A in MLL-r leukemia and therapeutic response | 000 | 4 | NIH | 3/17/2022 | $356,164 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK120523 | Regulation of beta-cell homeostasis by DNA methylation and hydroxymethylation. | 001 | 4 | NIH | 4/7/2022 | $43,250 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK120523 | Regulation of beta-cell homeostasis by DNA methylation and hydroxymethylation. | 000 | 4 | NIH | 1/28/2022 | $389,250 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK119590 | Microenvironmental cues control pancreas cell fate and beta-cell maturation | 000 | 5 | NIH | 7/14/2022 | $408,208 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA215183 | Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma | 000 | 5 | NIH | 8/19/2022 | $451,162 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | T32CA221709 | Cancer Metabolism Training Program | 000 | 5 | NIH | 8/19/2022 | $219,265 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA233431 | Yes 2 Success | 001 | 4 | NIH | 8/25/2022 | $0 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA233431 | Yes 2 Success | 000 | 4 | NIH | 2/15/2022 | $485,999 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL141336 | Targeting protein acetylation as a therapeutic approach for MDS | 001 | 5 | NIH | 7/25/2022 | $43,250 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL141336 | Targeting protein acetylation as a therapeutic approach for MDS | 000 | 5 | NIH | 2/24/2022 | $389,250 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA228465 | PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity | 001 | 5 | NIH | 5/19/2022 | $31,675 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA228465 | PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity | 000 | 5 | NIH | 2/28/2022 | $356,338 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R37CA233691 | Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia | 001 | 4 | NIH | 4/29/2022 | $39,574 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R37CA233691 | Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia | 000 | 4 | NIH | 11/24/2021 | $356,164 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | UG1HL069278 | City of Hope Core Clinical Center for the Blood and Marrow Transplant Clinical Trials Network | 001 | 22 | NIH | 7/1/2022 | $207,600 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | F32CA247311 | Using Cultured Human Mammary Epithelial Cells to Explore the Role of the Yap Oncogene in Early Breast Cancer Progression | 000 | 4 | NIH | 8/18/2022 | $71,734 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01NS106170 | Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin | 000 | 4 | NIH | 12/29/2021 | $337,421 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01NS106170 | Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin | 001 | 4 | NIH | 3/31/2022 | $37,491 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA205247 | Targeting MicroRNAs to Eradicate Leukemia Stem Cells | 000 | 6 | NIH | 8/4/2022 | $505,757 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R35CA210087 | Human natural killer cells: Advancing biology and clinical applications | 000 | 6 | NIH | 6/30/2022 | $954,486 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R50CA211397 | Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers | 001 | 7 | NIH | 8/22/2022 | $377,434 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | T32CA186895 | DNA Damage Response and Oncogenic Signaling | 002 | 6 | NIH | 6/23/2022 | $3,940 |
|
